Testimonials From Strategic Market Access Planning for Orphan Drugs

The Optimising Access for Orphan and Rare Diseases course was an excellent overview of the market access challenges in the ever-evolving space of rare and orphan diseases. The presenters were very knowledgeable and shared a lot of their experiences in the disease area.

Clinigen Group

Janet Lac, Consulting Associate - United Kingdom - December 2022 (live online course)
The most beautiful thing about this course is that you can definitely learn new things, no matter whether you already have experience in access or you don't.


Marian Marocico, Patient Access and Launch Excellence Lead - Romania - December 2022 (live online course)
Excellent training course led by very knowledgeable trainers! Well worth the time and cost!


Mattias Klefbeck, New Product Planning Lead Nordics - Sweden - December 2022 (live online course)